Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
about
Lung cancer susceptibility model based on age, family history and genetic variantsApoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancerAssociation of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studiesFAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controlsThe FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studiesFasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significancesAssociation of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association studyFASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjectsAssociations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjectsInternational Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variantsInteractions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinomaAssociation of Fas -1377 G/A polymorphism with susceptibility to cancerDeath receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian populationFAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South AfricansFAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese populationGenetic association between CD95 rs2234767 polymorphism and cervical cancer risk: a meta analysis.Polymorphisms in apoptosis-related genes and TP53 mutations in non-small cell lung cancerThe combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South AfricaSite disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neckApoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese PopulationFASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.DNA methylation-mediated nucleosome dynamics and oncogenic Ras signaling: insights from FAS, FAS ligand and RASSF1A.Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.CASP-8 -652 6N ins/del polymorphism and cancer risk: A literature-based systematic HuGE review and meta-analysis.CASP-1, -2 and -5 gene polymorphisms and cancer risk: A review and meta-analysisFunctional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.Polymorphisms of the FAS and FASL genes and risk of breast cancer.Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma.Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.Genetic variation in the LMP/TAP gene and outcomes of hepatitis B virus infection in the Chinese population.Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.Fas gene variants in childhood acute lymphoblastic leukemia and association with prognosis.
P2860
Q21091204-46EF9C07-A25F-4056-9A5D-5C931DB1259FQ23918557-41F0C5D6-9673-4342-A65E-D8935D64EA77Q26859155-38A19DB7-7604-4DF8-A3F2-161333AAB686Q26866492-2610F94A-D6CC-4A55-BF0B-91B4A981C701Q28384635-DFF7DCE7-9C4E-4959-8D65-1F2DB254EC35Q28385359-B78B9190-F0F4-4D1F-A022-63464236A3CAQ28387253-36716C7C-7682-4F0B-A9C6-6A118FBB9262Q28389021-AE69CF8F-6B3F-4F13-AACB-2F6C498CBD7FQ28391896-120EF7A0-E877-49EE-A4A4-2F01D2E26FF1Q28394515-3921084F-EF68-4786-97DF-D8BC9FB451EAQ28396031-8B01DA0B-7407-4358-B2B5-C6D9CDEED309Q28396240-76B115AE-EE00-4099-90F1-226F004EB575Q28396733-42091ABD-D8AC-4218-8BCB-C734F6AE0259Q31124204-47FC3B20-E892-4F09-B8A0-45C7AC699E6AQ33516711-86DBD0CD-57E6-4437-8C3E-AB69150A6669Q33903227-AC969069-E7CB-482D-9FC5-6269698BE313Q34551169-91A98622-32D5-44F5-98DA-7A429466E4DAQ34950211-B2E7B9BF-2AD6-408F-8238-C6227F12A5C3Q35480353-3BF873FE-6C08-477D-9A27-07A17433AF10Q35511710-43393F40-B46A-4D81-922A-C93E53EAE97DQ35803679-7ED3CEA7-9B42-4DB6-93DF-B37DD9E0B322Q35917835-2CFCC1A2-9AC6-4EFA-8409-E0671E909A5BQ36075038-7BAE1EE7-CE7C-4CCA-A357-A0E3A63677A9Q36159307-E011EA12-4021-461A-92C6-89F19D451927Q36403535-3212776C-3607-4AB4-9744-6892492C8B58Q36797318-97174861-2839-45F0-84C3-4830AB9154AEQ37273862-FE2E55B1-2BE6-4F3D-9C16-54FDF0C3D408Q37293815-8125AAC6-3CD1-433A-86A0-3982C591CE3EQ37736549-99554D13-CB66-4EB5-B13F-D4D5E62CB9D7Q38061422-4BA2F0A9-CFAB-47DE-AEB6-C0DCB4828137Q38197615-01F51282-DA10-4598-B63F-48376B019046Q38435201-717F6043-79FA-45CD-BADE-50C528651FFAQ38689483-F97D2A60-CD68-4384-A09F-CE55C7C4B454Q41811141-B58152A1-EF0D-41F3-A8F4-25504E628B87Q43522247-61DD0EA3-DD2F-4153-93E2-08E601149CE1Q44049307-A992000B-668E-4F07-B7A9-B1166BD7D3A8Q44258365-64C82D7D-4146-4719-AFDE-DCA69B3E9529Q45375501-9ABEDC70-C8C8-4D52-A4DB-CDA25F184959Q45377890-0A2E8237-9B9E-43D7-9808-BDAEBA4C84F4Q46986190-160A7726-514D-441F-B5F4-5AC31A6D604A
P2860
Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@ast
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@en
type
label
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@ast
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@en
prefLabel
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@ast
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@en
P2093
P2860
P356
P1476
Functional polymorphisms in ce ...... ribute to risk of lung cancer.
@en
P2093
P2860
P304
P356
10.1136/JMG.2004.030106
P407
P577
2005-06-01T00:00:00Z